tiprankstipranks
Advertisement
Advertisement

SE:MVIR Stock Latest News

Company AnnouncementsMedivir targets Asian partnerships as it showcases liver cancer and bone disease drugs
12d ago
PremiumCompany Announcements
Medivir Delays Q1 Report as South Korea Liver Cancer Trial Expands
16d ago
PremiumCompany Announcements
Medivir Calls 2026 AGM, Details Shareholder Voting Procedures and Capital Structure
25d ago
Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
PremiumCompany Announcements
Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
1M ago
Medivir forms elite expert council to drive MIV-711 push in brittle bone disease
PremiumCompany Announcements
Medivir forms elite expert council to drive MIV-711 push in brittle bone disease
1M ago
Medivir to Showcase Phase 2 Advances for Key Cancer and Bone Disease Programs
PremiumCompany AnnouncementsMedivir to Showcase Phase 2 Advances for Key Cancer and Bone Disease Programs
2M ago
Medivir Names New CFO to Steer Next Phase of Strategic Transformation
Premium
Company Announcements
Medivir Names New CFO to Steer Next Phase of Strategic Transformation
2M ago
Medivir Expands Share Capital After Directed Issue to Carl Bennet AB
Premium
Company Announcements
Medivir Expands Share Capital After Directed Issue to Carl Bennet AB
2M ago
Medivir sharpens rare-disease and liver cancer focus after financing and licensing deals
PremiumCompany Announcements
Medivir sharpens rare-disease and liver cancer focus after financing and licensing deals
2M ago
Medivir Partner Vetbiolix Launches Key Study of Potential Blockbuster Canine Periodontitis Drug
PremiumCompany Announcements
Medivir Partner Vetbiolix Launches Key Study of Potential Blockbuster Canine Periodontitis Drug
3M ago
Medivir Raises SEK 45 Million in Directed Share Issue to Carl Bennet AB
PremiumCompany Announcements
Medivir Raises SEK 45 Million in Directed Share Issue to Carl Bennet AB
3M ago
Medivir Raises SEK 45 Million in Premium Directed Share Issue to Fund New Rare-Disease Program
PremiumCompany Announcements
Medivir Raises SEK 45 Million in Premium Directed Share Issue to Fund New Rare-Disease Program
3M ago
Medivir names nomination committee ahead of 2026 AGM
PremiumCompany AnnouncementsMedivir names nomination committee ahead of 2026 AGM
3M ago
Medivir to Highlight Key Liver Cancer Study at Redeye Fight Cancer Event 2026
Premium
Company Announcements
Medivir to Highlight Key Liver Cancer Study at Redeye Fight Cancer Event 2026
3M ago
Medivir Reshapes Board Leadership at Extraordinary General Meeting
Premium
Company Announcements
Medivir Reshapes Board Leadership at Extraordinary General Meeting
4M ago
Medivir Boosts Share Capital and Expands Share Base After Rights Issue
PremiumCompany Announcements
Medivir Boosts Share Capital and Expands Share Base After Rights Issue
4M ago
Medivir Calls Extraordinary General Meeting with Expanded Voting Options
PremiumCompany Announcements
Medivir Calls Extraordinary General Meeting with Expanded Voting Options
5M ago
Medivir AB Announces CFO Departure Amid Ongoing Cancer Treatment Developments
PremiumCompany Announcements
Medivir AB Announces CFO Departure Amid Ongoing Cancer Treatment Developments
5M ago
Medivir AB Secures SEK 151 Million Through Rights Issue
PremiumCompany Announcements
Medivir AB Secures SEK 151 Million Through Rights Issue
5M ago
Medivir to Present Promising Liver Cancer Study at Redeye Life Science Day
PremiumCompany AnnouncementsMedivir to Present Promising Liver Cancer Study at Redeye Life Science Day
5M ago
Medivir’s Partner Vetbiolix Publishes Landmark Study on Canine Periodontitis Treatment
Premium
Company Announcements
Medivir’s Partner Vetbiolix Publishes Landmark Study on Canine Periodontitis Treatment
5M ago
Medivir’s MIV-711 Receives FDA Orphan Drug Designation for Osteogenesis Imperfecta
Premium
Company Announcements
Medivir’s MIV-711 Receives FDA Orphan Drug Designation for Osteogenesis Imperfecta
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >